Journal of Enzyme Inhibition and Medicinal Chemistry · 2011 · 47 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryAnalgesic PharmacologyAnthelmintic PharmacologyAntibacterial PharmacologyStructure-activity Relationship AnalysisActivitiesAnthelmintic AgentsAnthelmintic Drug ClassesAnthelmintic Drug DevelopmentAnthelmintic Drug TherapyBenzothiazole SynthesisConcentrationNovel Antibacterial Drug Discovery
In the present investigation, synthesis and anti-bacterial, analgesic and anthelmintic evaluation of a novel series of fluoroquinolone derivatives clubbed with benzothiazole moeity has been described. The synthesized compounds were characterised by spectral analysis (IR and (1)H NMR). Preliminary results indicated that the most of the synthesized compounds demonstrated good activities against gram negative and gram positive bacterial strains. Compounds 5a, 5b, 5f and 5k demonstrated potent anti-bacterial activities. Compound 5a exhibited most potent anti-bacterial activity with MIC values of 04, 03, 08 and 15 µg/ mL against B. subtilis, S. aureus, E. coli and P. aeruginosa. Analogs 5a, 5c, 5g and 5h showed promising anthelmintic activity against Eisemia foetida in a low concentration as compared to standard drug piperazine citrate with mean paralysis time ranging 22.60 ± 2.46 to 31.60 ± 3.07 min. All synthesized compounds depicted good in vivo analgesic activity with compound 5a exhibiting the most potent activity of 55.19% inhibition of writhing in comparison to the standard drug.
23
Y. Asahina, Kazuhiko Iwase, Fujio Iinuma et al. · Journal of Medicinal Chemistry · 2005 · 103 citations · Full text
Joëlle Azéma, Brigitte Guidetti, Janique Dewelle et al. · Bioorganic & Medicinal Chemistry · 2009 · 91 citations · Full text